【 Direct Attack on the China International Expo 】 Experience the "Spillover Effect" of China International Expo, Geely's Second Exhibition Expands Its Moments in China
两把木椅狭
发表于 2023-11-9 12:00:15
1332
0
0
Xinhua Finance and Economics, Shanghai, November 9 (Reporter Du Kang) - Geely Science, a leading global biopharmaceutical company, has embarked on its second "journey to enter the international market" this year. From the "first time customer" who participated in the exhibition last year to the "repeat customer" who went to the CIIE again this year, Geely Science witnessed the rapid launch of drugs on display and witnessed the spillover effects brought by the CIIE. Geely Science stated that it looks forward to further expanding its "circle of friends" in China with the help of "Jinbo Magnetic Force".
In 2017, Geely officially began commercial operations in China, with drugs covering viral hepatitis, HIV prevention and treatment, as well as antifungal infections and tumors. At present, eleven innovative drugs have been approved in China, of which eight have been included in the national medical insurance catalog.
Jin Fangqian, Global Vice President and General Manager of Geely Science in China, said, "Last year, Geely participated for the first time and witnessed the spillover effects brought by the CIIE. We have personally witnessed the rapid launch of drugs on display. This year, when we go to CIIE again, we look forward to sharing Geely's rapid development and future plans in China with all sectors of society on such an open platform, accelerating the introduction of innovative products and continuously improving drug accessibility
It is worth mentioning that the innovative drug Tuodawei& Reg; And products in the field of antifungal agents, Anbisoft& Reg; Two drugs were first exhibited at the CIIE last year and have been successfully launched in China this year, rapidly achieving patient accessibility. This year's CIIE, Geely China comprehensively presented its "star" innovative drugs in the fields of HIV prevention and treatment, viral hepatitis, tumors, and antifungal agents.
In 2022, Gilead launched the construction of local research and development team and research and development capacity in China. In less than a year, it has promoted the rapid development of 14 Phase II/III clinical research projects, including 11 Phase II/III tumor clinical studies covering breast cancer, lung cancer, urogenital tumors, digestive tract tumors and gynecological tumors, and 3 anti-virus Phase III clinical studies. In addition, Geely also demonstrated plans to introduce innovative product indications for clinical research in China.
Thanks to the favorable policies of the country in promoting high-quality development and encouraging innovation, Geely has achieved rapid development since entering China for six years. "Jin Fangqian stated that China is one of Geely's three important strategic markets globally. Looking forward to further expanding the "circle of friends" of the medical ecosystem in China through the "Jinbo Magnetic Force".
The reporter learned that Geely will sign a series of contracts with China's ecological partners in the future, including signing a strategic cooperation memorandum with Jinyu Medical to assist in early diagnosis, treatment, and standardized treatment of diseases; Signed strategic cooperation memorandums with Shulan (Hangzhou) Hospital and Tunchang Branch of Hainan Provincial People's Hospital to support the prevention and treatment of viral hepatitis in Hangzhou and Hainan; Signed strategic cooperation with the Hainan Boao Lecheng International Medical Tourism Pilot Zone Management Bureau and Sichuan University West China Lecheng Hospital to promote the pilot trial of innovative drugs in the field of cancer in Boao.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Zeng Yuqun, owner of car 001! Baidu, Geely cooperate to set new car prices
- Yizi International expands its business in China and adds equity investment in Enxi Village
- Yizi International further expands its business in China and significantly increases its equity investment in Enxi Village
- Yizi International further expands its business in China and significantly increases its equity investment in Enxi Village
- Jin Fangqian, Global Vice President of Gilead Sciences: Continue to increase investment in China and bring Chinese innovative drugs to the world
- China International Import Expo opens listening mode, 'all students' look forward to the prospects of the Chinese market
- Insiders: Jike plans to acquire a majority stake in Lynk&Co, a sister brand of Geely and Volvo
- Geely's Jike and Lynk&Co 'integration': Jike spent over 9.3 billion yuan to acquire 51% equity of Lynk&Co
- Geely Group undergoes strategic integration, with Lynk&Co merging into Jike. The new group's annual production and sales target millions
- Optimizing the equity structure of Jike and Lynk&Co, Geely Holding's strategic transformation enters a new stage
-
11月21日、2024世界インターネット大会烏鎮サミットで、創業者、CEOの周源氏が大会デジタル教育フォーラムとインターネット企業家フォーラムでそれぞれ講演、発言したことを知っている。周源氏によると、デジタル教 ...
- 不正经的工程师
- 昨天 16:36
- 支持
- 反对
- 回复
- 收藏
-
スターバックスが中国事業の株式売却の可能性を検討していることが明らかになった。 11月21日、外国メディアによると、スターバックスは中国事業の株式売却を検討している。関係者によると、スターバックスは中国事 ...
- 献世八宝掌
- 前天 16:29
- 支持
- 反对
- 回复
- 收藏
-
【意法半導体CEO:中国市場は非常に重要で華虹と協力を展開】北京時間11月21日、意法半導体(STM.N)は投資家活動の現場で、同社が中国ウェハー代工場の華虹公司(688347.SH)と協力していると発表した。伊仏半導体 ...
- 黄俊琼
- 前天 14:29
- 支持
- 反对
- 回复
- 收藏
-
【ナスダック中国金龍指数は1%下落した。人気の中概株の多くは下落した】現地時間11月21日、ナスダック中国金龍指数は1%下落し、人気の中概株の多くは下落し、必死に10%超下落し、愛奇芸は7%超下落し、百度は6%近く ...
- 比尔992
- 昨天 11:57
- 支持
- 反对
- 回复
- 收藏